Browse by Journal Title

Article

A computational model for prediction of ferritin and haemoglobin levels in blood donors.
Paalvast, Y., Moazzen, S., Sweegers, M., Hogema, B., Janssen, M. and van den Hurk, K.
British Journal of Haematology 199 (1): 143-152. October 2022

A phase II trial to evaluate the combination of pixantrone and obinutuzumab for patients with relapsed aggressive lymphoma: Final results of the prospective, multicentre GOAL trial.
Hess, G., Hüttmann, A., Witzens-Harig, M., Dreyling, M.H., Keller, U., Marks, R., Ernst, T., Pott, C., Viardot, A., Frontzek, F., Trautmann, M., Ruckes, C., Deuster, O., Rosenwald, A., Theobald, M. and Lenz, G.
British Journal of Haematology 198 (3): 482-491. 1 April 2022

Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012).
Baras, N., Dahm, S., Haberland, J., Janz, M., Emrich, K., Kraywinkel, K. and Salama, A.
British Journal of Haematology 177 (2): 226-242. April 2017

Targeted sequencing using a 47 gene multiple myeloma mutation panel (M(3) P) in -17p high risk disease.
Kortüm, K.M., Langer, C., Monge, J., Bruins, L., Egan, J.B., Zhu, Y.X., Shi, C.X., Jedlowski, P., Schmidt, J., Ojha, J., Bullinger, L., Liebisch, P., Kull, M., Champion, M.D., Van Wier, S., Ahmann, G., Rasche, L., Knop, S., Fonseca, R., Einsele, H., Stewart, A.K. and Braggio, E.
British Journal of Haematology 168 (4): 507-510. February 2015

Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis.
Lietz, A., Janz, M., Sigvardsson, M., Jundt, F., Doerken, B. and Mathas, S.
British Journal of Haematology 137 (4): 342-348. May 2007

Vaccination with autologous non-irradiated dendritic cells in patients with bcr/abl+ chronic myeloid leukaemia.
Westermann, J., Kopp, J., van Lessen, A., Hecker, A.C., Baskaynak, G., le Coutre, P., Doehner, K., Doehner, H., Doerken, B. and Pezzutto, A.
British Journal of Haematology 137 (4): 297-306. May 2007

Simultaneous cytokine analysis by cytometric bead array for the detection of leukaemia-reactive T cells in patients with chronic myeloid leukaemia.
Westermann, J., Lessen, A., Schlimper, C., Baskaynak, G., Coutre, P., Doerken, B. and Pezzutto, A.
British Journal of Haematology 132 : 32-35. January 2006

Empirical antimicrobial monotherapy in patients after high-dose chemotherapy and autologous stem cell transplantation: a randomised, multicentre trial.
Reich, G., Cornely, O.A., Sandherr, M., Kubin, T., Krause, S., Einsele, H., Thiel, E., Bellaire, T., Doerken, B. and Maschmeyer, G.
British Journal of Haematology 130 : 265-270. 1 July 2005

T cell recognition of bcr/abl in healthy donors and in patients with chronic myeloid leukaemia.
Westermann, J., Schlimper, C., Richter, G., Mohm, J., Doerken, B. and Pezzutto, A.
British Journal of Haematology 125 (2): 213-216. 1 April 2004

Filgrastim-induced stem cell mobilization in chronic myeloid leukaemia patients during imatinib therapy: safety, feasibility and evidence for an efficient in vivo purging.
Kreuzer, K.A., Kluehs, C., Baskaynak, G., Movassaghi, K., Doerken, B. and Le Coutre, P.
British Journal of Haematology 124 (2): 195-199. 1 January 2004

Alveolar rhabdomyosarcoma with bone marrow infiltration mimicking haematological neoplasia.
Maywald, O., Metzgeroth, G., Schoch, C., Ludwig, W.D., Neff, W., Hehlmann, R. and Hastka, J.
British Journal of Haematology 119 : 583. 1 December 2002

Fluorescent 5'-exonuclease assay for the absolute quantification of Wilms' tumour gene (WT1) mRNA: implications for monitoring human leukaemias.
Kreuzer, K.A., Saborowski, A., Lupberger, J., Appelt, C., Na, I.K., le Coutre, P. and Schmidt, C.A.
British Journal of Haematology 114 (2): 313-318. August 2001

Spectral karyotyping and fluorescence in situ hybridization detect novel chromosomal aberrations, a recurring involvement of chromosome 21 and amplification of the MYC oncogene in acute myeloid leukaemia M2.
Hilgenfeld, E., Padilla-Nash, H., McNeil, N., Knutsen, T., Montagna, C., Tchinda, J., Horst, J., Ludwig, W.D., Serve, H., Buechner, T., Berdel, W.E., Schroeck, E. and Ried, T.
British Journal of Haematology 113 : 305-317. 1 May 2001

Acute myeloid leukaemia MO: haematological, immunophenotypic and cytogenetic characteristics and their prognostic significance: an analysis in 241 patients.
Bene, M.C., Bernier, M., Casasnovas, R.O., Castoldi, G., Doekharan, D., van der Holt, B., Knapp, W., Lemez, P., Ludwig, W.D., Matutes, E., Orfao, A., Schoch, C., Sperling, C. and van't Veer, M.B.
British Journal of Haematology 113 : 737-745. 1 January 2001

Constitutive expression levels of CD95 and Bcl-2 as well as CD95 function and spontaneous apoptosis in vitro do not predict the response to induction chemotherapy and relapse rate in childhood acute lymphoblastic leukaemia.
Wuchter, C., Karawajew, L., Ruppert, V., Schrappe, M., Harbott, J., Ratei, R., Doerken, B. and Ludwig, W.D.
British Journal of Haematology 110 : 154-160. 1 July 2000

Mutation analysis of CD95 (APO-1/Fas) in childhood B-lineage acute lymphoblastic leukaemia.
Beltinger, C., Boehler, T., Karawajew, L., Ludwig, W.D., Schrappe, M. and Debatin, K.M.
British Journal of Haematology 102 : 722-728. 1 August 1998

Correlation of cytogenetic, molecular cytogenetic, and clinical findings in 59 patients with ANLL or MDS and abnormalities of the short arm of chromosome 12.
Streubel, B., Sauerland, C., Heil, G., Freund, M., Bartels, H., Lengfelder, E., Wandt, H., Ludwig, W.D., Nowotny, H., Baldus, M., Grothaus-Pinke, B., Buechner, T. and Fonatsch, C.
British Journal of Haematology 100 : 521-533. 1 March 1998

Immunophenotypic and clinical features of T-cell receptor gammadelta+ T-lineage acute lymphoblastic leukaemia.
Schott, G., Sperling, C., Schrappe, M., Ratei, R., Martin, M., Meyer, U., Riehm, H. and Ludwig, W.D.
British Journal of Haematology 101 : 753-755. 1 January 1998

New insights into the biology of Philadelphia-chromosome-positive acute lymphoblastic leukaemia using a combination of May-Grunwald-Giemsa staining and fluorescence in situ hybridization techniques at the single cell level.
Haferlach, T., Winkemann, M., Ramm-Petersen, L., Meeder, M., Schoch, R., Weber-Matthiesen, K., Schlegelberger, B., Schoch, C., Ludwig, W.D., Hiddemann, W. and Loffler, H.
British Journal of Haematology 99 : 452-459. 1 November 1997

Morphological and cytochemical findings in 150 cases of T-lineage acute lymphoblastic leukemia in adults.
Gassmann, W., Loeffler, H., Thiel, E., Ludwig, W.D., Schwartz, S., Haferlach, T., Maurer, J., Rieder, H., Fonatsch, C., Goekbuget, N. and Hoelzer, D.
British Journal of Haematology 97 : 372-382. 1 January 1997

Expression of intercellular adhesion molecule 1 (ICAM-1) in childhood acute lymphoblastic leukemia: correlation with clinical features and outcome.
Mielcarek, M., Sperling, C., Schrappe, M., Meyer, U., Riehm, H. and Ludwig, W.D.
British Journal of Haematology 96 : 301-307. 1 January 1997

Prognostic significance of additional chromosome abnormalities in adult patients with philadelphia chromosome positive acute lymphoblastic leukaemia.
Rieder, H., Ludwig, W.D., Gassmann, W., Maurer, J., Janssen, J.W., Gokbuget, N., Schwartz, S., Thiel, E., Loeffler, H., Bartram, C.R., Hoelzer, D. and Fonatsch, C.
British Journal of Haematology 95 : 678-691. 1 January 1997

Acute myeloid and T-cell acute lymphoblastic leukaemia with aberrant antigen expression exhibit similar TCRdelta gene rearrangements.
Schmidt, C.A., Przybylski, G., Tietze, A., Oettle, H., Siegert, W. and Ludwig, W.D.
British Journal of Haematology 92 (4): 929-936. 1 January 1996

Secondary acute leukaemias with 11q23 rearrangement: clinical, cytogenetic, fish and fiction studies.
Zhao, Y.M., Poetsch, M., Weber-Matthiesen, K., Rohde, G., Winkemann, M., Haferlach, T., Gassmann, W., Ludwig, W.D., Grote, W., Loeffler, H. and Schlegelberger, B.
British Journal of Haematology 92 (3): 673-680. 1 January 1996

The fusion of TEL and ABL in human acute lymphoblastic leukaemia is a rare event.
Janssen, J.W., Ridge, S.A., Papadopoulos, P., Cotter, F., Ludwig, W.D., Fonatsch, C., Rieder, H., Ostertag, W., Bartram, C.R. and Wiedemann, L.M.
British Journal of Haematology 90 (1): 222-224. 1 January 1995

Molecular characterization of illegitimate TCRdelta gene rearrangements in acute myeloid leukaemia.
Przybylski, G., Oettle, H., Ludwig, W.D., Siegert, W. and Schmidt, C.A.
British Journal of Haematology 87 : 301-307. 1 January 1994

Detection of herpesvirus type 6 by polymerase chain reaction in blood donors: random tests and prospective longitudinal studies.
Wilborn, F., Schmidt, C.A., Zimmermann, R., Brinkmann, V., Neipel, F. and Siegert, W.
British Journal of Haematology 88 : 187-192. 1 January 1994

Lymphotoxin, tumour necrosis factor and interleukin-6 gene transcripts are present in Hodgkin and Reed-Sternberg cells of most Hodgkin's disease cases.
Foss, H.D., Herbst, H., Oelmann, E., Samol, J., Grebe, M., Blankenstein, T., Matthes, J., Qin, Z., Falini, B., Pileri, S., Diamantstein, T. and Stein, H.
British Journal of Haematology 84 (4): 627-635. 1 August 1993

Letter

Expression of CD274 (PD-L1) is associated with unfavourable recurrent mutations in AML.
Zajac, M., Zaleska, J., Dolnik, A., Bullinger, L. and Giannopoulos, K.
British Journal of Haematology 183 (5): 822-825. December 2018

Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab versus chemotherapy plus rituximab for relapsed/refractory aggressive B-cell non-Hodgkin lymphoma.
Dang, N.H., Ogura, M., Castaigne, S., Fayad, L.E., Jerkeman, M., Radford, J., Pezzutto, A., Bondarenko, I., Stewart, D.A., Shnaidman, M., Sullivan, S., Vandendries, E., Tobinai, K., Ramchandren, R., Hamlin, P.A., Giné, E. and Ando, K.
British Journal of Haematology 182 (4): 583-586. August 2018

BAY 43-9006/Sorafenib blocks CSF1R activity and induces apoptosis in various classical Hodgkin lymphoma cell lines.
Ullrich, K., Wurster, K.D., Lamprecht, B., Koechert, K., Engert, A., Doerken, B., Janz, M. and Mathas, S.
British Journal of Haematology 155 (3): 398-402. November 2011

Monitoring oral anticoagulant therapy in patients with lupus anticoagulants.
Ortel, T.L. and Moll, S.
British Journal of Haematology 101 : 390-392. 1 May 1998

CD34 expression in de novo acute myeloid leukaemia.
Sperling, C., Buechner, T., Sauerland, C., Fonatsch, C., Thiel, E. and Ludwig, W.D.
British Journal of Haematology 85 : 635-637. 1 January 1993